What is the most common mutation causing thyroid cancer?

What is the most common mutation causing thyroid cancer?

• A. RET gene loss of function
• B. BRCA 1 deletion
• C. p16/INK4a loss of function
• D. BCR-ABL translocation

Answer: (A)

The most common mutation associated with thyroid cancer is indeed related to the RET gene. This gene is pivotal because it encodes a protein that functions as a receptor tyrosine kinase, which plays a critical role in cell signaling pathways that control cell proliferation and differentiation. In particular, specific chromosomal rearrangements, such as RET/PTC, result in the activation of the RET gene, which can lead to the development of certain types of thyroid cancers, notably papillary thyroid carcinoma. Mutations affecting the RET gene are often a result of fusion events or point mutations, which disrupt normal regulatory mechanisms and lead to uncontrolled cellular growth. This is especially relevant in familial cases, such as multiple endocrine neoplasia type 2 (MEN 2), where inherited mutations in RET are directly linked to an increased risk of developing medullary thyroid carcinoma. While other mutations and deletions can contribute to different forms of cancer or may be implicated in other malignancies, they are not the primary mutations linked to thyroid cancer specifically. For instance, BRCA1 is primarily associated with breast and ovarian cancer, p16/INK4a is more closely related to melanoma and certain types of head and neck cancers, and the BCR-ABL translocation is classically associated with

The most common mutation associated with thyroid cancer is indeed related to the RET gene. This gene is pivotal because it encodes a protein that functions as a receptor tyrosine kinase, which plays a critical role in cell signaling pathways that control cell proliferation and differentiation. In particular, specific chromosomal rearrangements, such as RET/PTC, result in the activation of the RET gene, which can lead to the development of certain types of thyroid cancers, notably papillary thyroid carcinoma.

Mutations affecting the RET gene are often a result of fusion events or point mutations, which disrupt normal regulatory mechanisms and lead to uncontrolled cellular growth. This is especially relevant in familial cases, such as multiple endocrine neoplasia type 2 (MEN 2), where inherited mutations in RET are directly linked to an increased risk of developing medullary thyroid carcinoma.

While other mutations and deletions can contribute to different forms of cancer or may be implicated in other malignancies, they are not the primary mutations linked to thyroid cancer specifically. For instance, BRCA1 is primarily associated with breast and ovarian cancer, p16/INK4a is more closely related to melanoma and certain types of head and neck cancers, and the BCR-ABL translocation is classically associated with